Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.

Xie F, Li C, Zhang X, Peng W, Wen T.

Biomed Pharmacother. 2019 Nov;119:109424. doi: 10.1016/j.biopha.2019.109424. Epub 2019 Sep 12.

2.

Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.

Wang C, Sun Y, Wu H, Yu S, Zhang L, Meng Y, Liu M, Yang H, Liu P, Mao X, Lu Z, Chen J.

Tumour Biol. 2015 Dec;36(12):9447-56. doi: 10.1007/s13277-015-3690-x. Epub 2015 Jun 30.

PMID:
26124009
3.

MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.

Hu J, Li L, Chen H, Zhang G, Liu H, Kong R, Chen H, Wang Y, Li Y, Tian F, Lv X, Li G, Sun B.

Cell Death Dis. 2018 Jul 24;9(8):807. doi: 10.1038/s41419-018-0839-8.

4.

miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.

Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchêne B, Leteurtre E, Mariette C, Torrisani J, Jonckheere N, Van Seuningen I.

Oncogene. 2015 Feb 5;34(6):780-8. doi: 10.1038/onc.2014.11. Epub 2014 Mar 10.

PMID:
24608432
5.

The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.

Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J.

Carcinogenesis. 2010 Oct;31(10):1726-33. doi: 10.1093/carcin/bgq160. Epub 2010 Jul 30.

PMID:
20675343
6.

miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.

Liu G, Ji L, Ke M, Ou Z, Tang N, Li Y.

Biomed Pharmacother. 2018 Oct;106:523-531. doi: 10.1016/j.biopha.2018.06.114. Epub 2018 Jul 11.

PMID:
29990840
7.

MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.

Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S.

Oncotarget. 2016 Mar 22;7(12):14912-24. doi: 10.18632/oncotarget.7482.

8.

MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.

Xia X, Zhang K, Cen G, Jiang T, Cao J, Huang K, Huang C, Zhao Q, Qiu Z.

Oncotarget. 2015 Aug 28;6(25):21046-63.

9.

Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.

Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J.

J Exp Clin Cancer Res. 2018 Jul 3;37(1):130. doi: 10.1186/s13046-018-0807-2.

10.

Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.

Li Q, Ran P, Zhang X, Guo X, Yuan Y, Dong T, Zhu B, Zheng S, Xiao C.

Cell Physiol Biochem. 2018;50(3):987-1004. doi: 10.1159/000494482. Epub 2018 Oct 24.

11.

MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.

Mou T, Xie F, Zhong P, Hua H, Lai L, Yang Q, Wang J.

Biomed Pharmacother. 2019 Mar;111:891-900. doi: 10.1016/j.biopha.2018.12.121. Epub 2019 Jan 7.

12.

MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.

Dang Z, Xu WH, Lu P, Wu N, Liu J, Ruan B, Zhou L, Song WJ, Dou KF.

Int J Biol Sci. 2014 Jun 24;10(7):733-45. doi: 10.7150/ijbs.8097. eCollection 2014.

13.
14.

Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.

Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, Zou Y, Chen S.

J Exp Clin Cancer Res. 2019 Jul 15;38(1):310. doi: 10.1186/s13046-019-1313-x.

15.

MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1.

Chen ZM, Yu Q, Chen G, Tang RX, Luo DZ, Dang YW, Wei DM.

Cancer Manag Res. 2019 May 27;11:4825-4837. doi: 10.2147/CMAR.S199257. eCollection 2019.

16.

microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1.

Cao R, Shao J, Hu Y, Wang L, Li Z, Sun G, Gao X.

Cancer Cell Int. 2018 Apr 2;18:49. doi: 10.1186/s12935-018-0551-x. eCollection 2018.

17.

miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.

Ta N, Huang X, Zheng K, Zhang Y, Gao Y, Deng L, Zhang B, Jiang H, Zheng J.

Cell Physiol Biochem. 2018;51(2):711-728. doi: 10.1159/000495328. Epub 2018 Nov 21.

18.

The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.

Mokhlis HA, Bayraktar R, Kabil NN, Caner A, Kahraman N, Rodriguez-Aguayo C, Zambalde EP, Sheng J, Karagoz K, Kanlikilicer P, Abdel Aziz AAH, Abdelghany TM, Ashour AA, Wong S, Gatza ML, Calin GA, Lopez-Berestein G, Ozpolat B.

Mol Ther Nucleic Acids. 2019 Mar 1;14:301-317. doi: 10.1016/j.omtn.2018.11.019. Epub 2018 Dec 13.

19.

RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.

Luo Z, Yi ZJ, Ou ZL, Han T, Wan T, Tang YC, Wang ZC, Huang FZ.

J Cell Physiol. 2019 Apr;234(4):3583-3597. doi: 10.1002/jcp.27039. Epub 2018 Oct 26.

PMID:
30362505
20.

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors.

Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, Tsim N, Vlavianos P, Cohen P, Ahmad R, Keller A, Habib NA, Stebbing J, Castellano L.

PLoS One. 2012;7(2):e32068. doi: 10.1371/journal.pone.0032068. Epub 2012 Feb 22.

Supplemental Content

Support Center